Alta Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
1,026
+2
+0.2% +$2.04K 0.09% 66
2026
Q1
$942K Buy
1,024
+17
+2% +$17.2K 0.07% 69
2025
Q4
$1.08M Sell
1,007
-12
-1% -$11.5K 0.07% 68
2025
Q3
$777K Sell
1,019
-16
-2% -$11.9K 0.04% 70
2025
Q2
$807K Hold
1,035
0.05% 67
2025
Q1
$855K Buy
1,035
+21
+2% +$17.5K 0.06% 67
2024
Q4
$783K Buy
1,014
+14
+1% +$11.6K 0.05% 68
2024
Q3
$886K Hold
1,000
0.05% 64
2024
Q2
$905K Hold
1,000
0.06% 65
2024
Q1
$778K Sell
1,000
-1,500
-60% -$1.07M 0.05% 67
2023
Q4
$1.46M Buy
+2,500
New +$1.46M 0.09% 62

Other funds holding LLY

Alta Capital Management's LLY Position: Q2 2026 in Review

Alta Capital Management increased its Eli Lilly (LLY) stake by 0.2% in Q2 2026, buying an estimated $2.04K and bringing the position to 1,026 shares worth $1.23M. The position accounts for 0.09% of the portfolio, ranked #66.

Alta Capital Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.46M in Q4 2023. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alta Capital Management held 1,026 shares of Eli Lilly worth $1.23M as of Q2 2026.
  • Alta Capital Management bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.09% of Alta Capital Management's portfolio in Q2 2026, its #66 holding.
  • Alta Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Alta Capital Management's Eli Lilly position peaked at $1.46M in Q4 2023.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alta Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.